What Is Panic Disorder? Panic Attacks, Agoraphobia, and Treatment

What Is a Panic Attack?

A panic attack is a discrete episode of intense fear or discomfort that reaches a peak within minutes and involves four or more of the following symptoms: palpitations or pounding heart, sweating, trembling or shaking, shortness of breath or feeling smothered, choking sensation, chest pain or discomfort, nausea or abdominal distress, dizziness or lightheadedness, chills or hot flushes, paresthesias (numbness or tingling), derealization (feelings of unreality) or depersonalization (feeling detached from oneself), fear of losing control or going crazy, and fear of dying. Panic attacks can occur in the context of various anxiety disorders, in other psychiatric conditions, or following drug use—the defining feature of panic disorder is that at least some attacks are unexpected, occurring without an obvious external trigger.

Panic attacks are experienced as overwhelmingly frightening and often feel life-threatening. Many people experiencing their first panic attack believe they are having a heart attack, a stroke, or dying, and present to emergency departments. Indeed, the cardiovascular symptoms—racing heart, chest tightness, shortness of breath—mimic cardiac events, and distinguishing panic from genuine cardiac emergencies sometimes requires medical investigation. The physical symptoms are real and physiologically produced—not imagined—but their cause is psychological arousal rather than cardiac pathology.

The Fight-or-Flight Response Gone Wrong

The physiology of a panic attack is essentially the fight-or-flight response—the evolutionary alarm system activated by perceived life-threatening danger—triggered inappropriately in the absence of actual danger. When the brain's threat-detection system (centered on the amygdala) perceives danger, it activates the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system, releasing adrenaline (epinephrine) and noradrenaline. These stress hormones produce rapid heart rate (to pump blood to muscles), increased respiratory rate (to increase oxygen supply), sweating (for thermoregulation during exertion), muscle tension, and heightened alertness.

In panic disorder, this system becomes sensitized and triggers in response to internal bodily sensations (a slightly elevated heart rate, a momentary dizziness, a deep breath) rather than genuine external threats. The cognitive model of panic, developed by David Clark, proposes that panic attacks arise from the catastrophic misinterpretation of benign bodily sensations: a person notices their heart beating slightly faster, interprets this as a sign of impending heart attack, which generates anxiety, which further increases heart rate, which is perceived as confirmation of the feared catastrophe—a positive feedback loop that escalates to a full panic attack within minutes. This model has been remarkably influential both in understanding panic disorder and in designing highly effective psychological interventions.

Panic Disorder Diagnosis and Agoraphobia

The DSM-5 diagnosis of panic disorder requires: recurrent unexpected panic attacks; at least one month following an attack of persistent concern about additional attacks or their consequences, or significant maladaptive behavior related to the attacks (such as avoiding exercise, unfamiliar situations, or leaving home). The disorder occurs in approximately 2–3% of the population and is about twice as common in women as in men. Onset is typically in early adulthood, often between ages 20–35.

Agoraphobia—the fear and avoidance of situations in which escape might be difficult or help unavailable in the event of a panic attack—commonly co-occurs with panic disorder (in up to 50% of cases), though the DSM-5 now classifies it as a separate diagnosis. Feared and avoided situations typically include public transportation, open spaces, enclosed places, crowds, and being outside the home alone. In severe cases, agoraphobia can render a person completely housebound. Once established, avoidance behavior maintains and strengthens the anxiety by preventing the person from learning that the feared catastrophe (dying, losing control, humiliation) does not occur—a key mechanism that exposure therapy specifically targets.

Cognitive Behavioral Therapy for Panic Disorder

CBT is the most evidence-supported psychological treatment for panic disorder, with response rates of 80–90% in clinical trials and superiority to medication in terms of long-term durability. CBT for panic disorder has several core components. Psychoeducation about the physiology of panic—understanding that panic symptoms are the fight-or-flight response and not dangerous—begins to break the catastrophic misinterpretation cycle. Cognitive restructuring involves identifying and challenging the specific catastrophic misinterpretations (e.g., 'my racing heart means I'm having a heart attack') by evaluating evidence and generating more accurate alternative interpretations.

Interoceptive exposure is a distinctive technique in panic disorder CBT: deliberately inducing feared physical sensations (by spinning in a chair to cause dizziness, breathing through a straw to simulate breathlessness, or doing jumping jacks to increase heart rate) in a controlled therapeutic setting, to repeatedly demonstrate that these sensations are safe and tolerable. This directly addresses the fear of physical sensations that maintains panic disorder. In vivo exposure to avoided situations (public transport, shopping centers, crowded spaces) is conducted hierarchically—starting with less feared situations and progressing to more feared ones—until avoidance is extinguished. Breathing retraining (diaphragmatic breathing, slowing the respiratory rate) may help manage hyperventilation during exposure, though modern CBT places less emphasis on breathing control and more on direct exposure to feared sensations.

Pharmacological Treatment

SSRIs and SNRIs are first-line pharmacological treatments for panic disorder and are typically used in combination with CBT for moderate-to-severe cases, or alone when CBT is not available. Effective agents include escitalopram, sertraline, paroxetine, fluoxetine (all SSRIs), and venlafaxine (SNRI). A clinically important consideration is that SSRIs can temporarily increase anxiety and precipitate panic attacks during the first 1–2 weeks of treatment (a 'jitteriness syndrome'), which must be anticipated and managed—typically by starting at low doses and increasing gradually.

Benzodiazepines (clonazepam, alprazolam) provide rapid relief of panic symptoms but carry risks of dependence, cognitive impairment, and rebound anxiety upon discontinuation, and critically, they interfere with the extinction learning that is the mechanism of CBT. For this reason, benzodiazepines are now considered second-line or adjunctive therapies, used for short-term symptom management while waiting for SSRIs to take effect or in severe, treatment-resistant cases. They should never be used as needed immediately before entering feared situations, as this undermines exposure therapy. The combination of medication and CBT generally produces better outcomes than either alone for panic disorder, and CBT's benefits are more durable after treatment ends than medication effects alone.